StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.73+0.13 (+5.00%)

Close on Nov 18, 2026Market cap $156.11MP/E –Yield –

Abeona Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Abeona Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $25.52M. For fiscal 2025 it was $5.82M, up 66.3% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $10.00M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.82M+66.3%
FY2023Dec 31, 2023$3.50M+147.5%
FY2022Dec 31, 2022$1.41M-52.9%
FY2021Dec 31, 2021$3.00M-70.0%
FY2020Dec 31, 2020$10.00M+233.6%
FY2018Dec 31, 2018$3.00M+258.2%
FY2017Dec 31, 2017$837.00K-5.8%
FY2016Dec 31, 2016$889.00K-14.5%
FY2015Dec 31, 2015$1.04M+12.4%
FY2014Dec 31, 2014$925.00K-54.7%
FY2013Dec 31, 2013$2.04M-53.6%
FY2012Dec 31, 2012$4.40M+139.5%
FY2011Dec 31, 2011$1.84M+282.3%
FY2010Dec 31, 2010$481.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.38M+2745.0%
Q1 FY2026Mar 31, 2026$8.72M–
Q4 FY2025Dec 31, 2025$5.42M–
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$400.00K+488.2%
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$3.50M+911.6%
Q4 FY2022Dec 31, 2022$68.00K-97.7%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$1.00M–
Q1 FY2022Mar 31, 2022$346.00K–
Q4 FY2020Dec 31, 2020$3.00M+522.4%
Q3 FY2020Sep 30, 2020$7.00M+309.6%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$0-100.0%
Q4 FY2018Dec 31, 2018$482.00K+124.2%
Q3 FY2018Sep 30, 2018$1.71M+680.4%
Q2 FY2018Jun 30, 2018$276.00K+27.2%
Q1 FY2018Mar 31, 2018$531.00K+185.5%
Q4 FY2017Dec 31, 2017$215.00K-16.0%
Q3 FY2017Sep 30, 2017$219.00K+19.0%
Q2 FY2017Jun 30, 2017$217.00K–
Q1 FY2017Mar 31, 2017$186.00K–
Q4 FY2016Dec 31, 2016$256.00K–
Q3 FY2016Sep 30, 2016$184.00K–

More Abeona Therapeutics figures

See a number that looks wrong?